NCT02201199 - Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

insulin glargine U200 HOE901

Pharmaceutical form:solution for injection Route of administration: subcutaneous

DRUG

insulin glargine U500 HOE901

Pharmaceutical form:solution for injection Route of administration: subcutaneous

DRUG

insulin glargine U100 HOE901

Pharmaceutical form:solution for injection Route of administration: subcutaneous

Trial Locations (1)

Investigational Site Number 276001, Neuss